Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial



Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari
et al (show 12 more authors) (2021) Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. LANCET ONCOLOGY, 22 (5). 690 - 701.

[img] Text
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06) a phase 3, open-lab.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 06 Jul 2021 13:17
Last Modified: 13 Oct 2021 02:10
DOI: 10.1016/S1470-2045(21)00027-9
Open Access URL: https://www.thelancet.com/journals/lanonc/article/...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3129018